AKEBIA THERAPEUTICS INC shareholders Q3 2023

AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 79 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.4%.

AKEBIA THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
VANGUARD GROUP INC 7,521,317$8,574,3020.00%
Private Advisor Group, LLC 16,141$18,4000.00%
Focused Wealth Management, Inc 65$740.00%
JANE STREET GROUP, LLC 60,171$68,5950.00%
Capital Advisors, Ltd. LLC 320$00.00%
RAYMOND JAMES & ASSOCIATES 20,221$23,0520.00%
UBS Group AG 68,728$78,3490.00%
RHUMBLINE ADVISERS 4,926$5,6150.00%
NewEdge Advisors, LLC 2,535$2,8900.00%
PRUDENTIAL FINANCIAL INC 47,509$54,1600.00%
Baird Financial Group, Inc. 12,743$14,5270.00%
BNP PARIBAS FINANCIAL MARKETS 8,848$10,0870.00%
TWO SIGMA INVESTMENTS, LP 27,461$31,3060.00%
OSAIC HOLDINGS, INC. 739$8420.00%
FMR LLC 638,090$727,4230.00%
FIFTH THIRD BANCORP 3,300$3,7620.00%
FRANKLIN RESOURCES INC 65,083$74,1950.00%
BANK OF AMERICA CORP /DE/ 224,078$255,4490.00%
Russell Investments Group, Ltd. 187,750$214,0340.00%
WELLS FARGO & COMPANY/MN 11,013$12,5550.00%
External links

This page lists AKEBIA THERAPEUTICS INC's shareholders in Q3 2023. To view AKEBIA THERAPEUTICS INC's shareholder history, click here.